The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines ... The current presentation of the vaccine consists of a lyophilised (powder) antigen and a liquid adjuvant, which healthcare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results